Resonance Pharma, Inc

Resonance Pharma, Inc is a pioneering company in the development stage, focused on creating precision-enabled therapeutics to tackle critical health challenges. Established in 2022 and based in Ann Arbor, Michigan, this biopharma and biotechnology startup aims to address health issues such as sepsis, cancer, and infection. With a vision to revolutionize the pharmaceutical industry, Resonance Pharma presents a promising opportunity for venture capital investors seeking to support cutting-edge solutions in the health care sector. With no publicly disclosed last investment or investment partners, Resonance Pharma represents an emerging prospect with potential for growth and impact.